Premium
Reply to direct‐acting antiviral drugs and hepatitis C virus: A therapeutic revolution?
Author(s) -
Li Darrick K.,
Chung Raymond T.
Publication year - 2015
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.29650
Subject(s) - medicine , tolerability , hepatocellular carcinoma , hepatitis c , intensive care medicine , hepatitis c virus , pegylated interferon , oncology , ribavirin , immunology , virus , adverse effect